The Menstrual Cramps Treatment Market Growth is Accelerated by Increased Adoption of Alternative Treatments
Menstrual cramps are painful spasms occurring in the lower abdomen due to the contractions of the uterus during menstruation. Traditional treatments available for menstrual cramps include over-the-counter pain medicines such as ibuprofen and naproxen. However, there has been an increased demand for alternative treatment options such as yoga, meditation, acupuncture, massage, and transcutaneous electrical nerve stimulation (TENS) therapy due to their minimal side effects.
The global Menstrual
Cramps Treatment Market is estimated to be valued at US$ 652.3 Mn in 2023
and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to
2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising adoption of alternative treatments for menstrual cramps is one of
the major key trends being witnessed in the menstrual cramps treatment market.
These alternative treatments are significantly gaining popularity as they
involve non-invasive procedures without any side effects. For instance,
acupuncture therapy is found effective in reducing menstrual cramps by more
than 50% and is preferred by many women over conventional pain medicines.
Similarly, therapies like yoga, massage, and meditation help in relaxing the
muscles of the uterus and lowering stress levels to get relief from menstrual
pain. Furthermore, TENS therapy involves using electric pulses to block pain
signals in the nerves and provides pain relief. Thus, the increasing awareness
about various alternative treatment options and their effectiveness is expected
to boost the growth of the menstrual cramps treatment market during the
forecast period.
Segment Analysis
The global menstrual cramps treatment market can be segmented based on type
into nonsteroidal anti-inflammatory drugs (NSAIDs), hormonal contraceptives,
heating pads, and others. NSAIDs dominates the global menstrual cramps
treatment market as they are inexpensive and easily accessible over-the-counter
drugs that provide quick relief from menstrual pain and cramps.
Key Takeaways
The global menstrual cramps treatment market is expected to
witness high growth.
Key players: Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie), Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other. Stryker Corporation and Allergan (Abbvie) are the leading players in the global market owing to their diversified product portfolio and strong global presence across regions.
Comments
Post a Comment